Syk expression in non-small-cell lung cancer and its relation with angiogenesis

J Cancer Res Ther. 2016 Apr-Jun;12(2):663-6. doi: 10.4103/0973-1482.154082.

Abstract

Objective: To study the expression of spleentyrosine kinase (Syk) gene in non--small--cell lung cancer and the relationship between Syk mRNA and microvessel density (MVD) in the tumor cells.

Materials and methods: The expression of Syk gene in 70 cases of lung tumor tissues, adjacent tissues, and normal lung tissues were examined with reverse transcription polymerase chain reaction (RT--PCR). The expression of MVD was examined with immunohistochemical streptavidin--biotin complex (SABC). The relation between them was analyzed.

Results: Syk mRNA expression rates were 5.7, 95.7, and 100% in tumor, adjacent lung cells, and normal lung cells, respectively. The expression rate in tumor cells was significantly lower compared with those in normal lung tissue and adjacent lung tissue (P < 0.05), expression rate among different pathologic types, differentiation and clinical stages did not reveal any statistically significant differences (P > 0.05). The positive rate of CD34 in tumor was higher than that in adjacent tissues and normal lung tissues. The expression of Syk mRNA and MVD were negatively correlated.

Conclusions: The lack of Syk mRNA expression in lung cancer play an important role in angiogenesis.

MeSH terms

  • Adult
  • Aged
  • Antigens, CD34 / analysis
  • Carcinoma, Non-Small-Cell Lung / blood supply*
  • Carcinoma, Non-Small-Cell Lung / pathology
  • Female
  • Humans
  • Lung Neoplasms / blood supply*
  • Lung Neoplasms / pathology
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Neovascularization, Pathologic / etiology*
  • Syk Kinase / genetics
  • Syk Kinase / physiology*

Substances

  • Antigens, CD34
  • SYK protein, human
  • Syk Kinase